Molecure appoints Piotr Lutostanski and Molecure stock costs EUR 1.51

Published on 10/08/2026 at 16:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The EUR 1.51 quote dated October 8, 2026 followed EUR 1.50. Molecure stock stood at EUR 1.51 versus EUR 1.50, a plus 0.67 percent change.

Molecure, PLONCTH00011, Illustration mit AI erstellt.

Molecure (ISIN PLONCTH00011) was trading at EUR 1.51 at Lang & Schwarz on October 8, 2026 at 4:02 p.m. CEST, up 0.67 percent from EUR 1.50. The Polish biotechnology company appointed Piotr Lutostanski to its supervisory board on October 6, 2026, according to EspiCore.

A new board member joins

The appointment followed Robert Oskard's resignation from the supervisory board on October 2, 2026. Bankier.pl reported that the resignation took effect on the same date and carried no stated justification. Lutostanski had previously served on the board in 2015, according to the appointment report.

What do the half-year numbers mean?

Molecure's operating revenue fell to PLN 1.86 million in the first half of 2026 from PLN 3.52 million in the first half of 2025, a decline of 47.08 percent. The total comprehensive loss narrowed to PLN 6.31 million from PLN 8.52 million, an improvement of 25.98 percent, according to Parkiet. Operating cash flow was negative PLN 1.39 million in the same period, compared with negative PLN 10.64 million a year earlier.

Dates and the clinical pipeline

Molecure's investor calendar lists October 30, 2026 for its third-quarter 2026 report and November 9 to November 11, 2026 for BIO Europe in Cologne, according to the company's investor overview. The company describes five research programs, with OATD-01 in a Phase II trial and OATD-02 in Phase I. Those milestones give the board change a wider setting: Molecure remains a development-stage biotech whose valuation depends on clinical progress as well as financial funding.

Stock holds above prior close

The Lang & Schwarz quote stood at EUR 1.51 on October 8, 2026 at 4:02 p.m. CEST, plus 0.67 percent versus the EUR 1.50 prior close. On the Warsaw Stock Exchange, Molecure was quoted at PLN 6.53 on October 8, 2026 at 3:45 p.m. CEST, while its market capitalization was PLN 161.4 million and its 52-week range was PLN 4.98 to PLN 9.04.

The further course of trading is shown by the continuously updated real-time quote of Molecure stock.